在 2006 年的一份文件中，美國食品和藥物管理局就承認，新冠疫苗等基因治療產品可能導致的延遲不良事件之一是癌症和自身免疫問題。

A document from 2006, the FDA acknowledged that one of the delayed adverse events that you could expect from a gene therapy product which the COVID jabs are cancer and autoimmune issues.
publielectoral.lat/s/NFSCHimalayaNews